HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
195662.0,278189,2187-12-29 07:02:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TEMPORARY PACEMAKER WIRES INSERTED - At [**2187-12-28**] 11:00 AM
 CARDIAC CATH - At [**2187-12-28**] 11:30 AM
 ARTERIAL LINE - START [**2187-12-28**] 12:00 PM
 CORDIS/INTRODUCER - START [**2187-12-28**] 12:00 PM
 ARTERIAL LINE - STOP [**2187-12-28**] 01:30 PM
 TRANSTHORACIC ECHO - At [**2187-12-28**] 03:00 PM
 BLOOD CULTURED - At [**2187-12-28**] 08:45 PM
   1 and 2
 URINE CULTURE - At [**2187-12-28**] 08:45 PM
   Post-cath check normal
   Started Integralin.  Did not receive for 3 hours (1:30-4:30) as not
   properly connected.
   Sustained VT for 30s x 3.  Appeared to be in Wenkeback prior.  Got
   lidocaine.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Lidocaine - 2 mg/min
   Other ICU medications:
   Insulin - Regular - [**2187-12-28**] 03:00 PM
   Heparin Sodium (Prophylaxis) - [**2187-12-28**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-29**] 07:00 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 37.8
C (100.1
   HR: 69 (40 - 97) bpm
   BP: 147/64(85) {106/56(72) - 150/76(91)} mmHg
   RR: 19 (15 - 90) insp/min
   SpO2: 96%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
    CO/CI (Fick): (3 L/min) / (1.5 L/min/m2)
   Mixed Venous O2% Sat: 44 - 44
   Total In:
                                                                  2,146 mL
                                                                    357 mL
   PO:
                                                                    300 mL
   TF:
   IVF:
                                                                    986 mL
                                                                    357 mL
   Blood products:
   Total out:
                                                                  1,050 mL
                                                                    400 mL
   Urine:
                                                                  1,050 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,096 mL
                                                                    -43 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa. Feet are cool.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   204 K/uL
   12.5 g/dL
   199 mg/dL
   1.4 mg/dL
   22 mEq/L
   4.0 mEq/L
   34 mg/dL
   98 mEq/L
   133 mEq/L
   35.3 %
   10.8 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
   WBC
   10.3
   11.8
   10.8
   Hct
   38.3
   35.1
   35.3
   Plt
   [**Telephone/Fax (3) 2185**]
   Cr
   1.6
   1.4
   TropT
   2.79
   2.32
   Glucose
   216
   199
   Other labs: PT / PTT / INR:13.7/25.2/1.2, CK / CKMB /
   Troponin-T:430/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Mg++:2.2 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix, integralin
   - Daily EKGs
   - Follow CE to peak
   - Will start captopril once Cr improving.  No beta-blocker while
   bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.
   - Will pace for hypotensive bradycardia but would prefer to have native
   rhythm if blood pressure tolerates.
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo on [**12-29**]
   .
   HYPERGLYCEMIA - Hyperglycemia may be refractory to MI, but likely
   represents longstanding undiagnosed diabetes.  Pseudohyponatremia from
   hyperglycemia likely responsible for hyponatremia, but patient will
   need significant rehydration and carefull electrolyte monitoring.
   - Insulin gtt
   - [**Hospital1 **] electrolytes
   - [**Last Name (un) 294**] consult once controlled
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.
   - Daily Cr.
   - Rehydration as tolerated
   - Will check urine protein & lytes tomorrow if not improved.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.
   Patient needs ECK at noon and 2 PM, and CBC at 5PM and 11AM, as well as
   CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be contact[**Name (NI) **] at
   30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Cordis/Introducer - [**2187-12-28**] 12:00 PM
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TEMPORARY PACEMAKER WIRES INSERTED - At [**2187-12-28**] 11:00 AM
 CARDIAC CATH - At [**2187-12-28**] 11:30 AM
 ARTERIAL LINE - START [**2187-12-28**] 12:00 PM
 CORDIS/INTRODUCER - START [**2187-12-28**] 12:00 PM
 ARTERIAL LINE - STOP [**2187-12-28**] 01:30 PM
 TRANSTHORACIC ECHO - At [**2187-12-28**] 03:00 PM
 BLOOD CULTURED - At [**2187-12-28**] 08:45 PM
   1 and 2
 URINE CULTURE - At [**2187-12-28**] 08:45 PM
   Post-cath check normal
   Started Integralin.  Did not receive for 3 hours (1:30-4:30) as not
   properly connected.
   Sustained VT for 30s x 3.  Appeared to be in Wenkeback prior.  Got
   lidocaine.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Lidocaine - 2 mg/min
   Other ICU medications:
   Insulin - Regular - [**2187-12-28**] 03:00 PM
   Heparin Sodium (Prophylaxis) - [**2187-12-28**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-29**] 07:00 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 37.8
C (100.1
   HR: 69 (40 - 97) bpm
   BP: 147/64(85) {106/56(72) - 150/76(91)} mmHg
   RR: 19 (15 - 90) insp/min
   SpO2: 96%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
    CO/CI (Fick): (3 L/min) / (1.5 L/min/m2)
   Mixed Venous O2% Sat: 44 - 44
   Total In:
                                                                  2,146 mL
                                                                    357 mL
   PO:
                                                                    300 mL
   TF:
   IVF:
                                                                    986 mL
                                                                    357 mL
   Blood products:
   Total out:
                                                                  1,050 mL
                                                                    400 mL
   Urine:
                                                                  1,050 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,096 mL
                                                                    -43 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa. Feet are cool.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   204 K/uL
   12.5 g/dL
   199 mg/dL
   1.4 mg/dL
   22 mEq/L
   4.0 mEq/L
   34 mg/dL
   98 mEq/L
   133 mEq/L
   35.3 %
   10.8 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
   WBC
   10.3
   11.8
   10.8
   Hct
   38.3
   35.1
   35.3
   Plt
   [**Telephone/Fax (3) 2185**]
   Cr
   1.6
   1.4
   TropT
   2.79
   2.32
   Glucose
   216
   199
   Other labs: PT / PTT / INR:13.7/25.2/1.2, CK / CKMB /
   Troponin-T:430/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Mg++:2.2 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix, integralin
   - Daily EKGs
   - Follow CE to peak
   - Will start captopril once Cr improving.  No beta-blocker while
   bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.
   - Will pace for hypotensive bradycardia but would prefer to have native
   rhythm if blood pressure tolerates.
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo on [**12-29**]
   .
   HYPERGLYCEMIA - Hyperglycemia may be refractory to MI, but likely
   represents longstanding undiagnosed diabetes.  Pseudohyponatremia from
   hyperglycemia likely responsible for hyponatremia, but patient will
   need significant rehydration and carefull electrolyte monitoring.
   - Insulin gtt
   - [**Hospital1 **] electrolytes
   - [**Last Name (un) 294**] consult once controlled
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.
   - Daily Cr.
   - Rehydration as tolerated
   - Will check urine protein & lytes tomorrow if not improved.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.
   Patient needs ECK at noon and 2 PM, and CBC at 5PM and 11AM, as well as
   CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be contact[**Name (NI) **] at
   30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Cordis/Introducer - [**2187-12-28**] 12:00 PM
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with no prior medical history, who presented with weakness, bradycardia, and hyperglycemia. He was diagnosed with a ST-elevation myocardial infarction (STEMI) and underwent stenting of the posterolateral RCA. The patient has significant right-sided infarction, elevated troponin and CK-MB, and is at high risk for poor myocardial recovery. He is receiving medical management with ASA, statin, Plavix, and Integralin, and will start captopril once his creatinine improves.

The patient has bradycardia, likely secondary to ischemia of the conduction system, and is being paced. He is also experiencing hyperglycemia, which may be refractory to MI, but likely represents longstanding undiagnosed diabetes. The patient has renal failure, suspecting acute renal failure in the setting of poor perfusion and hyperglycemic hypovolemia.

Potential Medical Complications:

1. Cardiac complications:
	* Further myocardial infarction or damage
	* Cardiac arrhythmias, including ventricular fibrillation or asystole
	* Cardiac failure or cardiogenic shock
2. Renal complications:
	* Acute kidney injury or failure
	* Chronic kidney disease or end-stage renal disease
3. Hyperglycemic complications:
	* Diabetic ketoacidosis or hyperosmolar hyperglycemic nonketotic syndrome
	* Hypoglycemia or hypokalemia
4. Bradycardic complications:
	* Hypotension or shock
	* Cardiac arrest or asystole
5. Pulmonary complications:
	* Pneumonia or respiratory failure
	* Pulmonary edema or acute respiratory distress syndrome
6. Infection complications:
	* Sepsis or septic shock
	* Urinary tract infection or other infections
7. Gastrointestinal complications:
	* Gastrointestinal bleeding or perforation
	* Pancreatitis or other gastrointestinal disorders

It is essential to closely monitor the patient's condition and adjust treatment accordingly to prevent or manage these potential complications."
195662.0,278189,2187-12-29 07:02:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TEMPORARY PACEMAKER WIRES INSERTED - At [**2187-12-28**] 11:00 AM
 CARDIAC CATH - At [**2187-12-28**] 11:30 AM
 ARTERIAL LINE - START [**2187-12-28**] 12:00 PM
 CORDIS/INTRODUCER - START [**2187-12-28**] 12:00 PM
 ARTERIAL LINE - STOP [**2187-12-28**] 01:30 PM
 TRANSTHORACIC ECHO - At [**2187-12-28**] 03:00 PM
 BLOOD CULTURED - At [**2187-12-28**] 08:45 PM
   1 and 2
 URINE CULTURE - At [**2187-12-28**] 08:45 PM
   Post-cath check normal
   Started Integralin.  Did not receive for 3 hours (1:30-4:30) as not
   properly connected.
   Sustained VT for 30s x 3.  Appeared to be in Wenkeback prior.  Got
   lidocaine.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Lidocaine - 2 mg/min
   Other ICU medications:
   Insulin - Regular - [**2187-12-28**] 03:00 PM
   Heparin Sodium (Prophylaxis) - [**2187-12-28**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-29**] 07:00 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 37.8
C (100.1
   HR: 69 (40 - 97) bpm
   BP: 147/64(85) {106/56(72) - 150/76(91)} mmHg
   RR: 19 (15 - 90) insp/min
   SpO2: 96%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
    CO/CI (Fick): (3 L/min) / (1.5 L/min/m2)
   Mixed Venous O2% Sat: 44 - 44
   Total In:
                                                                  2,146 mL
                                                                    357 mL
   PO:
                                                                    300 mL
   TF:
   IVF:
                                                                    986 mL
                                                                    357 mL
   Blood products:
   Total out:
                                                                  1,050 mL
                                                                    400 mL
   Urine:
                                                                  1,050 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,096 mL
                                                                    -43 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   204 K/uL
   12.5 g/dL
   199 mg/dL
   1.4 mg/dL
   22 mEq/L
   4.0 mEq/L
   34 mg/dL
   98 mEq/L
   133 mEq/L
   35.3 %
   10.8 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
   WBC
   10.3
   11.8
   10.8
   Hct
   38.3
   35.1
   35.3
   Plt
   [**Telephone/Fax (3) 2185**]
   Cr
   1.6
   1.4
   TropT
   2.79
   2.32
   Glucose
   216
   199
   Other labs: PT / PTT / INR:13.7/25.2/1.2, CK / CKMB /
   Troponin-T:430/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Mg++:2.2 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   .
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will start with
   NPH 14 [**Hospital1 **] plus sliding scale and uptitrate NPH as needed.
   - Will need PCP [**Last Name (NamePattern4) 2207**]
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
           1. IV access: Peripheral line Order date: [**12-28**] @ 1215
   12. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**12-29**] @ 1155
   2. IV access: Temporary central access (ICU) Location: Right Femoral,
   Date inserted: [**2187-12-28**] Order date: [**12-28**] @ [**2081**]
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale & Fixed Dose Order date: [**12-29**] @ 1421
   3. 75 mEq Sodium Bicarbonate/ 1000 mL 1/2 NS
   Continuous at 100 ml/hr for 1000 ml Order date: [**12-29**] @ 1410
   14. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-28**] @ 1212
   4. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-28**] @ [**2209**]
   15. Insulin 100 Units/100 ml NS @ 0-10 UNIT/HR IV DRIP TITRATE TO
   Titrate to BS < 160
   Fingersticks every hour  Order date: [**12-28**] @ 1217
   5. Aspirin EC 325 mg PO DAILY  Order date: [**12-28**] @ 1117
   16. Lidocaine 80 mg IV BOLUS ONCE Duration: 1 Doses Order date: [**12-28**] @
   2354
   6. Atorvastatin 80 mg PO DAILY  Order date: [**12-28**] @ 1244
   17. Lidocaine 2 mg/min IV DRIP INFUSION Duration: 24 Hours Start: After
   completion of bolus dose Order date: [**12-28**] @ 2354
   7. Atropine Sulfate 0.5 mg IV X1:PRN symptomatic bradycardia &
   hypotension
   [**Month (only) 11**] repeat up to 2 mg total (including Atropine during procedure).
   Order date: [**12-29**] @ 1309
   18. Nitroglycerin 0.05-0.2 mcg/kg/min IV DRIP TITRATE TO chest pain
   free  Order date: [**12-29**] @ 1203
   8. Captopril 6.25 mg PO TID
   Hold for SBP < 90  Order date: [**12-29**] @ 1801
   19. Senna 1 TAB PO BID:PRN  Order date: [**12-28**] @ 1405
   9. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-28**] @ 1117
   20. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-28**] @ 1215
   10. Docusate Sodium 100 mg PO BID PRN  Order date: [**12-28**] @ 1405
   21. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**12-28**] @ [**2081**]
   11. Eptifibatide 14.4 mg IV ONCE Duration: 1 Doses
   Then start drip  Order date: [**12-29**] @ 1201
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TEMPORARY PACEMAKER WIRES INSERTED - At [**2187-12-28**] 11:00 AM
 CARDIAC CATH - At [**2187-12-28**] 11:30 AM
 ARTERIAL LINE - START [**2187-12-28**] 12:00 PM
 CORDIS/INTRODUCER - START [**2187-12-28**] 12:00 PM
 ARTERIAL LINE - STOP [**2187-12-28**] 01:30 PM
 TRANSTHORACIC ECHO - At [**2187-12-28**] 03:00 PM
 BLOOD CULTURED - At [**2187-12-28**] 08:45 PM
   1 and 2
 URINE CULTURE - At [**2187-12-28**] 08:45 PM
   Post-cath check normal
   Started Integralin.  Did not receive for 3 hours (1:30-4:30) as not
   properly connected.
   Sustained VT for 30s x 3.  Appeared to be in Wenkeback prior.  Got
   lidocaine.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Lidocaine - 2 mg/min
   Other ICU medications:
   Insulin - Regular - [**2187-12-28**] 03:00 PM
   Heparin Sodium (Prophylaxis) - [**2187-12-28**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-29**] 07:00 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 37.8
C (100.1
   HR: 69 (40 - 97) bpm
   BP: 147/64(85) {106/56(72) - 150/76(91)} mmHg
   RR: 19 (15 - 90) insp/min
   SpO2: 96%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
    CO/CI (Fick): (3 L/min) / (1.5 L/min/m2)
   Mixed Venous O2% Sat: 44 - 44
   Total In:
                                                                  2,146 mL
                                                                    357 mL
   PO:
                                                                    300 mL
   TF:
   IVF:
                                                                    986 mL
                                                                    357 mL
   Blood products:
   Total out:
                                                                  1,050 mL
                                                                    400 mL
   Urine:
                                                                  1,050 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,096 mL
                                                                    -43 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   204 K/uL
   12.5 g/dL
   199 mg/dL
   1.4 mg/dL
   22 mEq/L
   4.0 mEq/L
   34 mg/dL
   98 mEq/L
   133 mEq/L
   35.3 %
   10.8 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
   WBC
   10.3
   11.8
   10.8
   Hct
   38.3
   35.1
   35.3
   Plt
   [**Telephone/Fax (3) 2185**]
   Cr
   1.6
   1.4
   TropT
   2.79
   2.32
   Glucose
   216
   199
   Other labs: PT / PTT / INR:13.7/25.2/1.2, CK / CKMB /
   Troponin-T:430/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Mg++:2.2 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   .
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will start with
   NPH 14 [**Hospital1 **] plus sliding scale and uptitrate NPH as needed.
   - Will need PCP [**Last Name (NamePattern4) 2207**]
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
           1. IV access: Peripheral line Order date: [**12-28**] @ 1215
   12. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**12-29**] @ 1155
   2. IV access: Temporary central access (ICU) Location: Right Femoral,
   Date inserted: [**2187-12-28**] Order date: [**12-28**] @ [**2081**]
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale & Fixed Dose Order date: [**12-29**] @ 1421
   3. 75 mEq Sodium Bicarbonate/ 1000 mL 1/2 NS
   Continuous at 100 ml/hr for 1000 ml Order date: [**12-29**] @ 1410
   14. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-28**] @ 1212
   4. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-28**] @ [**2209**]
   15. Insulin 100 Units/100 ml NS @ 0-10 UNIT/HR IV DRIP TITRATE TO
   Titrate to BS < 160
   Fingersticks every hour  Order date: [**12-28**] @ 1217
   5. Aspirin EC 325 mg PO DAILY  Order date: [**12-28**] @ 1117
   16. Lidocaine 80 mg IV BOLUS ONCE Duration: 1 Doses Order date: [**12-28**] @
   2354
   6. Atorvastatin 80 mg PO DAILY  Order date: [**12-28**] @ 1244
   17. Lidocaine 2 mg/min IV DRIP INFUSION Duration: 24 Hours Start: After
   completion of bolus dose Order date: [**12-28**] @ 2354
   7. Atropine Sulfate 0.5 mg IV X1:PRN symptomatic bradycardia &
   hypotension
   [**Month (only) 11**] repeat up to 2 mg total (including Atropine during procedure).
   Order date: [**12-29**] @ 1309
   18. Nitroglycerin 0.05-0.2 mcg/kg/min IV DRIP TITRATE TO chest pain
   free  Order date: [**12-29**] @ 1203
   8. Captopril 6.25 mg PO TID
   Hold for SBP < 90  Order date: [**12-29**] @ 1801
   19. Senna 1 TAB PO BID:PRN  Order date: [**12-28**] @ 1405
   9. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-28**] @ 1117
   20. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-28**] @ 1215
   10. Docusate Sodium 100 mg PO BID PRN  Order date: [**12-28**] @ 1405
   21. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**12-28**] @ [**2081**]
   11. Eptifibatide 14.4 mg IV ONCE Duration: 1 Doses
   Then start drip  Order date: [**12-29**] @ 1201<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following information is summarized:

* The patient is a 56-year-old male with no prior medical history, who presented with weakness, bradycardia, and hyperglycemia.
* He was diagnosed with a ST-elevation myocardial infarction (STEMI) and underwent stenting of the posterior-lateral RCA.
* The patient has a history of undiagnosed diabetes, as indicated by a hemoglobin A1c level of 11.9%.
* He is currently experiencing bradycardia, likely secondary to ischemia of the conduction system, and has been placed on a temporary pacemaker.
* The patient has acute renal failure, which is suspected to be secondary to poor perfusion and hyperglycemic hypovolemia.
* He is participating in a clinical trial, ICE-T-TIMI-49, which involves receiving tenecteplase or placebo during PCI for STEMIs.
* The patient's laboratory results show elevated troponin and CK-MB levels, indicating significant myocardial damage.
* His current medications include aspirin, statin, Plavix, and insulin, and he is scheduled to start captopril and uptitrate NPH as needed.

Potential medical complications that can arise include:

* Cardiac complications:
	+ Bradycardia may progress to asystole or cardiac arrest if not properly managed.
	+ Myocardial infarction may lead to cardiac rupture or ventricular dysfunction.
	+ Right-sided infarction may cause cardiac tamponade or pericarditis.
* Renal complications:
	+ Acute renal failure may progress to chronic kidney disease or end-stage renal disease if not properly managed.
	+ Hyperglycemia may exacerbate renal damage.
* Infectious complications:
	+ Bacterial or fungal infections may occur due to central line placement or other invasive procedures.
	+ Catheter-related bloodstream infections are a potential risk.
* Gastrointestinal complications:
	+ Gastrointestinal bleeding may occur due to anticoagulation therapy or other medications.
	+ Diarrhea or constipation may occur due to medication side effects or gastrointestinal motility disorders.
* Neurological complications:
	+ Ischemia or infarction of the brain may occur due to cardiac arrest or other complications.
	+ Neurological symptoms such as confusion, agitation, or seizures may occur due to medication side effects or other factors.

It is essential to closely monitor the patient's condition and adjust treatment accordingly to prevent or manage these potential complications."
195662.0,278189,2187-12-30 06:03:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 CORDIS/INTRODUCER - STOP [**2187-12-29**] 11:44 AM
 TEMPORARY PACEMAKER WIRES DISCONTINUED - At [**2187-12-29**] 11:45 AM
 CHEST PAIN - At [**2187-12-29**] 11:45 AM
 CARDIAC CATH - At [**2187-12-29**] 12:15 PM
   T 101  at 6AM
   Lidocaine stopped and pacer wire pulled.  Chest pain following pacer
   pulling.  Urgent cath showing no significant disease and widely patent
   PCA stent.  Urgent echo showed no significant change.  Patient
   continues to have ectopy.  Started on 14 NPH [**Hospital1 **].
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 950 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-30**] 05:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 38.3
C (101
   HR: 70 (62 - 72) bpm
   BP: 121/68(81) {116/58(73) - 160/81(101)} mmHg
   RR: 18 (16 - 26) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                  3,158 mL
                                                                    216 mL
   PO:
                                                                  1,310 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,848 mL
                                                                    156 mL
   Blood products:
   Total out:
                                                                  1,700 mL
                                                                    300 mL
   Urine:
                                                                  1,700 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,458 mL
                                                                    -84 mL
   Respiratory support
   O2 Delivery Device: None, Nasal cannula
   SpO2: 96%
   ABG: ///28/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     131
                               [image002.gif]
                                     95
                               [image002.gif]
                                     25
   [image004.gif]
   185
                                                                   AGap=11
   [image005.gif]
   3.4
                               [image002.gif]
                                     28
                               [image002.gif]
                                     1.2
   [image007.gif]
   CK: 273
   MB: Pnd
   Ca: 7.6 Mg: 2.3 P: 2.7 D
   91
                                                                      12.8
                                                            [image007.gif]
                                    11.4
   [image004.gif]
   214
                 [image008.gif]
   [image004.gif]
                                    30.8
   [image007.gif]
   PT: 14.8
   PTT: 46.9
   INR: 1.3
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   Cr
   1.6
   1.4
   1.2
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.6 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   .
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will uptitrate NPH
   to 17 U [**Hospital1 **] given elevated blood sugars.
   - Will need PCP [**Last Name (NamePattern4) 2207**]
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
             IV access: Peripheral line Order date: [**12-28**] @ 1215
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**12-29**] @ 1155
   2. IV access: Temporary central access (ICU) Location: Right Femoral,
   Date inserted: [**2187-12-28**] Order date: [**12-28**] @ [**2081**]
   12. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale & Fixed Dose Order date: [**12-29**] @ 1421
   3. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-28**] @ [**2209**]
   13. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-28**] @ 1212
   4. Aspirin EC 325 mg PO DAILY  Order date: [**12-28**] @ 1117
   14. Insulin 100 Units/100 ml NS @ 0-10 UNIT/HR IV DRIP TITRATE TO
   Titrate to BS < 160
   Fingersticks every hour  Order date: [**12-28**] @ 1217
   5. Atorvastatin 80 mg PO DAILY  Order date: [**12-28**] @ 1244
   15. Nitroglycerin 0.05-0.2 mcg/kg/min IV DRIP TITRATE TO chest pain
   free  Order date: [**12-29**] @ 1203
   6. Atropine Sulfate 0.5 mg IV X1:PRN symptomatic bradycardia &
   hypotension
   [**Month (only) 11**] repeat up to 2 mg total (including Atropine during procedure).
   Order date: [**12-29**] @ 1309
   16. Potassium Chloride 60 mEq PO ONCE Duration: 1 Doses
   Hold for K >  Order date: [**12-30**] @ 0532
   7. Captopril 6.25 mg PO TID
   Hold for SBP < 90  Order date: [**12-29**] @ 1801
   17. Senna 1 TAB PO BID:PRN  Order date: [**12-28**] @ 1405
   8. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-28**] @ 1117
   18. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-28**] @ 1215
   9. Docusate Sodium 100 mg PO BID PRN  Order date: [**12-28**] @ 1405
   19. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**12-28**] @ [**2081**]
   10. Eptifibatide 14.4 mg IV ONCE Duration: 1 Doses
   Then start drip  Order date: [**12-29**] @ 1201
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 CORDIS/INTRODUCER - STOP [**2187-12-29**] 11:44 AM
 TEMPORARY PACEMAKER WIRES DISCONTINUED - At [**2187-12-29**] 11:45 AM
 CHEST PAIN - At [**2187-12-29**] 11:45 AM
 CARDIAC CATH - At [**2187-12-29**] 12:15 PM
   T 101  at 6AM
   Lidocaine stopped and pacer wire pulled.  Chest pain following pacer
   pulling.  Urgent cath showing no significant disease and widely patent
   PCA stent.  Urgent echo showed no significant change.  Patient
   continues to have ectopy.  Started on 14 NPH [**Hospital1 **].
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 950 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-30**] 05:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 38.3
C (101
   HR: 70 (62 - 72) bpm
   BP: 121/68(81) {116/58(73) - 160/81(101)} mmHg
   RR: 18 (16 - 26) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                  3,158 mL
                                                                    216 mL
   PO:
                                                                  1,310 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,848 mL
                                                                    156 mL
   Blood products:
   Total out:
                                                                  1,700 mL
                                                                    300 mL
   Urine:
                                                                  1,700 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,458 mL
                                                                    -84 mL
   Respiratory support
   O2 Delivery Device: None, Nasal cannula
   SpO2: 96%
   ABG: ///28/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     131
                               [image002.gif]
                                     95
                               [image002.gif]
                                     25
   [image004.gif]
   185
                                                                   AGap=11
   [image005.gif]
   3.4
                               [image002.gif]
                                     28
                               [image002.gif]
                                     1.2
   [image007.gif]
   CK: 273
   MB: Pnd
   Ca: 7.6 Mg: 2.3 P: 2.7 D
   91
                                                                      12.8
                                                            [image007.gif]
                                    11.4
   [image004.gif]
   214
                 [image008.gif]
   [image004.gif]
                                    30.8
   [image007.gif]
   PT: 14.8
   PTT: 46.9
   INR: 1.3
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   Cr
   1.6
   1.4
   1.2
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.6 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   .
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will uptitrate NPH
   to 17 U [**Hospital1 **] given elevated blood sugars.
   - Will need PCP [**Last Name (NamePattern4) 2207**]
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
             IV access: Peripheral line Order date: [**12-28**] @ 1215
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**12-29**] @ 1155
   2. IV access: Temporary central access (ICU) Location: Right Femoral,
   Date inserted: [**2187-12-28**] Order date: [**12-28**] @ [**2081**]
   12. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale & Fixed Dose Order date: [**12-29**] @ 1421
   3. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-28**] @ [**2209**]
   13. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-28**] @ 1212
   4. Aspirin EC 325 mg PO DAILY  Order date: [**12-28**] @ 1117
   14. Insulin 100 Units/100 ml NS @ 0-10 UNIT/HR IV DRIP TITRATE TO
   Titrate to BS < 160
   Fingersticks every hour  Order date: [**12-28**] @ 1217
   5. Atorvastatin 80 mg PO DAILY  Order date: [**12-28**] @ 1244
   15. Nitroglycerin 0.05-0.2 mcg/kg/min IV DRIP TITRATE TO chest pain
   free  Order date: [**12-29**] @ 1203
   6. Atropine Sulfate 0.5 mg IV X1:PRN symptomatic bradycardia &
   hypotension
   [**Month (only) 11**] repeat up to 2 mg total (including Atropine during procedure).
   Order date: [**12-29**] @ 1309
   16. Potassium Chloride 60 mEq PO ONCE Duration: 1 Doses
   Hold for K >  Order date: [**12-30**] @ 0532
   7. Captopril 6.25 mg PO TID
   Hold for SBP < 90  Order date: [**12-29**] @ 1801
   17. Senna 1 TAB PO BID:PRN  Order date: [**12-28**] @ 1405
   8. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-28**] @ 1117
   18. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-28**] @ 1215
   9. Docusate Sodium 100 mg PO BID PRN  Order date: [**12-28**] @ 1405
   19. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**12-28**] @ [**2081**]
   10. Eptifibatide 14.4 mg IV ONCE Duration: 1 Doses
   Then start drip  Order date: [**12-29**] @ 1201<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with no prior medical history, who presented with weakness, bradycardia, and hyperglycemia, and was diagnosed with a ST-elevation myocardial infarction (STEMI) of the posterolateral RCA. He underwent stenting and was discharged from the cardiac catheterization lab with a temporary pacemaker. The patient's rhythm has progressed from complete heart block to 1st-degree atrioventricular block, and he is now off the pacemaker.

The patient's vital signs are stable, with a temperature of 101F, heart rate of 70 bpm, blood pressure of 121/68 mmHg, and respiratory rate of 18 breaths per minute. His oxygen saturation is 96% on room air. His physical examination reveals mild crackles at the bases of the lungs and soft, non-tender abdomen.

Laboratory results show elevated troponin and CK-MB levels, indicating significant myocardial damage. His creatinine level has improved, and he is being monitored for signs of volume overload.

The patient is on several medications, including aspirin, atorvastatin, clopidogrel, and eptifibatide, and is being treated with heparin for DVT prophylaxis.

Potential Medical Complications:

1. Bradycardia: The patient's bradycardia may worsen, leading to cardiac arrest or heart block.
2. Heart Failure: The patient's right-sided myocardial infarction may lead to heart failure, which could worsen his condition.
3. Renal Failure: The patient's hyperglycemia and poor cardiac output may lead to acute renal failure.
4. Sepsis: The patient's hyperglycemia and dehydration may increase his risk of developing sepsis.
5. Gastrointestinal Bleeding: The patient's use of anticoagulant medications and his history of gastrointestinal bleeding may increase his risk of bleeding complications.
6. Stroke: The patient's atrial fibrillation and history of STEMI may increase his risk of stroke.
7. Pulmonary Embolism: The patient's use of anticoagulant medications and his history of deep vein thrombosis may increase his risk of pulmonary embolism.
8. Infection: The patient's history of diabetes and poor wound healing may increase his risk of developing infections.
9. Cardiac Arrhythmias: The patient's history of atrial fibrillation and ventricular tachycardia may increase his risk of developing other cardiac arrhythmias.
10. Death: The patient's underlying medical conditions and the severity of his STEMI may increase his risk of death."
195662.0,278189,2187-12-30 06:03:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 CORDIS/INTRODUCER - STOP [**2187-12-29**] 11:44 AM
 TEMPORARY PACEMAKER WIRES DISCONTINUED - At [**2187-12-29**] 11:45 AM
 CHEST PAIN - At [**2187-12-29**] 11:45 AM
 CARDIAC CATH - At [**2187-12-29**] 12:15 PM
   T 101  at 6AM
   Lidocaine stopped and pacer wire pulled.  Chest pain following pacer
   pulling.  Urgent cath showing no significant disease and widely patent
   PCA stent.  Urgent echo showed no significant change.  Patient
   continues to have ectopy.  Started on 14 NPH [**Hospital1 **].
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 950 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-30**] 05:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 38.3
C (101
   HR: 70 (62 - 72) bpm
   BP: 121/68(81) {116/58(73) - 160/81(101)} mmHg
   RR: 18 (16 - 26) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                  3,158 mL
                                                                    216 mL
   PO:
                                                                  1,310 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,848 mL
                                                                    156 mL
   Blood products:
   Total out:
                                                                  1,700 mL
                                                                    300 mL
   Urine:
                                                                  1,700 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,458 mL
                                                                    -84 mL
   Respiratory support
   O2 Delivery Device: None, Nasal cannula
   SpO2: 96%
   ABG: ///28/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     131
                               [image002.gif]
                                     95
                               [image002.gif]
                                     25
   [image004.gif]
   185
                                                                   AGap=11
   [image005.gif]
   3.4
                               [image002.gif]
                                     28
                               [image002.gif]
                                     1.2
   [image007.gif]
   CK: 273
   MB: Pnd
   Ca: 7.6 Mg: 2.3 P: 2.7 D
   91
                                                                      12.8
                                                            [image007.gif]
                                    11.4
   [image004.gif]
   214
                 [image008.gif]
   [image004.gif]
                                    30.8
   [image007.gif]
   PT: 14.8
   PTT: 46.9
   INR: 1.3
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   Cr
   1.6
   1.4
   1.2
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.6 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   .
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will start with
   NPH 14 [**Hospital1 **] plus sliding scale and uptitrate NPH as needed.
   - Will need PCP [**Last Name (NamePattern4) 2207**]
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
             IV access: Peripheral line Order date: [**12-28**] @ 1215
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**12-29**] @ 1155
   2. IV access: Temporary central access (ICU) Location: Right Femoral,
   Date inserted: [**2187-12-28**] Order date: [**12-28**] @ [**2081**]
   12. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale & Fixed Dose Order date: [**12-29**] @ 1421
   3. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-28**] @ [**2209**]
   13. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-28**] @ 1212
   4. Aspirin EC 325 mg PO DAILY  Order date: [**12-28**] @ 1117
   14. Insulin 100 Units/100 ml NS @ 0-10 UNIT/HR IV DRIP TITRATE TO
   Titrate to BS < 160
   Fingersticks every hour  Order date: [**12-28**] @ 1217
   5. Atorvastatin 80 mg PO DAILY  Order date: [**12-28**] @ 1244
   15. Nitroglycerin 0.05-0.2 mcg/kg/min IV DRIP TITRATE TO chest pain
   free  Order date: [**12-29**] @ 1203
   6. Atropine Sulfate 0.5 mg IV X1:PRN symptomatic bradycardia &
   hypotension
   [**Month (only) 11**] repeat up to 2 mg total (including Atropine during procedure).
   Order date: [**12-29**] @ 1309
   16. Potassium Chloride 60 mEq PO ONCE Duration: 1 Doses
   Hold for K >  Order date: [**12-30**] @ 0532
   7. Captopril 6.25 mg PO TID
   Hold for SBP < 90  Order date: [**12-29**] @ 1801
   17. Senna 1 TAB PO BID:PRN  Order date: [**12-28**] @ 1405
   8. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-28**] @ 1117
   18. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-28**] @ 1215
   9. Docusate Sodium 100 mg PO BID PRN  Order date: [**12-28**] @ 1405
   19. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**12-28**] @ [**2081**]
   10. Eptifibatide 14.4 mg IV ONCE Duration: 1 Doses
   Then start drip  Order date: [**12-29**] @ 1201
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 CORDIS/INTRODUCER - STOP [**2187-12-29**] 11:44 AM
 TEMPORARY PACEMAKER WIRES DISCONTINUED - At [**2187-12-29**] 11:45 AM
 CHEST PAIN - At [**2187-12-29**] 11:45 AM
 CARDIAC CATH - At [**2187-12-29**] 12:15 PM
   T 101  at 6AM
   Lidocaine stopped and pacer wire pulled.  Chest pain following pacer
   pulling.  Urgent cath showing no significant disease and widely patent
   PCA stent.  Urgent echo showed no significant change.  Patient
   continues to have ectopy.  Started on 14 NPH [**Hospital1 **].
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 950 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-30**] 05:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (101
   Tcurrent: 38.3
C (101
   HR: 70 (62 - 72) bpm
   BP: 121/68(81) {116/58(73) - 160/81(101)} mmHg
   RR: 18 (16 - 26) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                  3,158 mL
                                                                    216 mL
   PO:
                                                                  1,310 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,848 mL
                                                                    156 mL
   Blood products:
   Total out:
                                                                  1,700 mL
                                                                    300 mL
   Urine:
                                                                  1,700 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,458 mL
                                                                    -84 mL
   Respiratory support
   O2 Delivery Device: None, Nasal cannula
   SpO2: 96%
   ABG: ///28/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     131
                               [image002.gif]
                                     95
                               [image002.gif]
                                     25
   [image004.gif]
   185
                                                                   AGap=11
   [image005.gif]
   3.4
                               [image002.gif]
                                     28
                               [image002.gif]
                                     1.2
   [image007.gif]
   CK: 273
   MB: Pnd
   Ca: 7.6 Mg: 2.3 P: 2.7 D
   91
                                                                      12.8
                                                            [image007.gif]
                                    11.4
   [image004.gif]
   214
                 [image008.gif]
   [image004.gif]
                                    30.8
   [image007.gif]
   PT: 14.8
   PTT: 46.9
   INR: 1.3
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   Cr
   1.6
   1.4
   1.2
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/8/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.6 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   .
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   .
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   .
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   .
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will start with
   NPH 14 [**Hospital1 **] plus sliding scale and uptitrate NPH as needed.
   - Will need PCP [**Last Name (NamePattern4) 2207**]
   .
   RENAL FAILURE - Suspect acute renal failure in setting of poor
   perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   .
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   .
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
             IV access: Peripheral line Order date: [**12-28**] @ 1215
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**12-29**] @ 1155
   2. IV access: Temporary central access (ICU) Location: Right Femoral,
   Date inserted: [**2187-12-28**] Order date: [**12-28**] @ [**2081**]
   12. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale & Fixed Dose Order date: [**12-29**] @ 1421
   3. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-28**] @ [**2209**]
   13. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-28**] @ 1212
   4. Aspirin EC 325 mg PO DAILY  Order date: [**12-28**] @ 1117
   14. Insulin 100 Units/100 ml NS @ 0-10 UNIT/HR IV DRIP TITRATE TO
   Titrate to BS < 160
   Fingersticks every hour  Order date: [**12-28**] @ 1217
   5. Atorvastatin 80 mg PO DAILY  Order date: [**12-28**] @ 1244
   15. Nitroglycerin 0.05-0.2 mcg/kg/min IV DRIP TITRATE TO chest pain
   free  Order date: [**12-29**] @ 1203
   6. Atropine Sulfate 0.5 mg IV X1:PRN symptomatic bradycardia &
   hypotension
   [**Month (only) 11**] repeat up to 2 mg total (including Atropine during procedure).
   Order date: [**12-29**] @ 1309
   16. Potassium Chloride 60 mEq PO ONCE Duration: 1 Doses
   Hold for K >  Order date: [**12-30**] @ 0532
   7. Captopril 6.25 mg PO TID
   Hold for SBP < 90  Order date: [**12-29**] @ 1801
   17. Senna 1 TAB PO BID:PRN  Order date: [**12-28**] @ 1405
   8. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-28**] @ 1117
   18. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-28**] @ 1215
   9. Docusate Sodium 100 mg PO BID PRN  Order date: [**12-28**] @ 1405
   19. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**12-28**] @ [**2081**]
   10. Eptifibatide 14.4 mg IV ONCE Duration: 1 Doses
   Then start drip  Order date: [**12-29**] @ 1201<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male who presented with a ST-elevation myocardial infarction (STEMI) and was diagnosed with a right-sided infarction. He underwent stenting of the posterolateral RCA and is currently being managed with medical therapy, including aspirin, statin, and clopidogrel. The patient has a history of hyperglycemia and was diagnosed with undiagnosed diabetes. He is also experiencing bradycardia, likely secondary to ischemia of the conduction system, and has been placed on a temporary pacemaker.

The patient's laboratory results show elevated troponin and CK-MB levels, indicating significant myocardial damage. His creatinine levels are elevated, suggesting acute renal failure, which is likely secondary to poor perfusion and hyperglycemic hypovolemia. His hemoglobin A1c level is 11.9, indicating chronic diabetes.

The patient is currently being treated with insulin and is being monitored for signs of volume overload. He is also being followed for potential complications such as renal failure and cardiac arrhythmias.

Potential medical complications that can arise:

1. Cardiac arrhythmias: The patient's bradycardia is likely to continue, and there is a risk of developing other cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia.
2. Renal failure: The patient's creatinine levels are elevated, and there is a risk of developing further renal failure if his blood pressure is not adequately controlled and his fluid status is not monitored closely.
3. Infection: The patient has a central line and is at risk of developing central line-associated bloodstream infection (CLABSI).
4. Bleeding: The patient is receiving anticoagulant therapy, and there is a risk of bleeding complications, such as gastrointestinal bleeding or hematuria.
5. Cardiac rupture: The patient's right-sided infarction is a risk factor for cardiac rupture, which can occur if the infarcted area of the heart becomes too large and compromises the integrity of the ventricular wall.
6. Chronic kidney disease: The patient's elevated creatinine levels and history of diabetes suggest that he may be at risk of developing chronic kidney disease.
7. Cardiovascular disease: The patient's history of STEMI and diabetes suggest that he may be at risk of developing further cardiovascular disease, such as recurrent myocardial infarction or heart failure.

These potential complications will need to be closely monitored and managed to prevent or minimize their impact on the patient's health."
195662.0,278189,2187-12-31 06:52:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
 BLOOD CULTURED - At [**2187-12-30**] 10:00 AM
   Decreased BM overnight, had temp of 100.5 at MN.  Urine Cx resent and
   pending.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2187-12-30**] 10:00 PM
   Other medications:
   NPH 17/17 + SSI
   ASA 325mg
   Clopidogrel 75mg
   Atorvastatin 80mg daily
   SCH
   Captopril 12.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-31**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.8
   Tcurrent: 37.4
C (99.4
   HR: 63 (62 - 74) bpm
   BP: 129/62(78) {110/55(67) - 138/71(84)} mmHg
   RR: 16 (15 - 22) insp/min
   SpO2: 98%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
                  Total In:
                                                                  1,310 mL
                                                                     60 mL
   PO:
                                                                  1,110 mL
                                                                     60 mL
   TF:
   IVF:
                                                                    200 mL
   Blood products:
   Total out:
                                                                  2,025 mL
                                                                      0 mL
   Urine:
                                                                  1,275 mL
   NG:
                                                                    250 mL
   Stool:
                                                                    500 mL
   Drains:
   Balance:
                                                                   -715 mL
                                                                     60 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   243 K/uL
   9.9 g/dL
   82 mg/dL
   1.1 mg/dL
   27 mEq/L
   3.5 mEq/L
   22 mg/dL
   101 mEq/L
   135 mEq/L
   27.9 %
   12.2 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
                            [**2187-12-31**]  05:00 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   12.2
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   27.9
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   243
   Cr
   1.6
   1.4
   1.2
   1.1
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   82
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/4/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.6 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will uptitrate NPH
   to 17 U [**Hospital1 **] given elevated blood sugars.
   - Will need PCP [**Name9 (PRE) 2207**]
   RENAL FAILURE
 Improving.  Suspect acute renal failure in setting of
   poor perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
 BLOOD CULTURED - At [**2187-12-30**] 10:00 AM
   Decreased BM overnight, had temp of 100.5 at MN.  Urine Cx resent and
   pending.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2187-12-30**] 10:00 PM
   Other medications:
   NPH 17/17 + SSI
   ASA 325mg
   Clopidogrel 75mg
   Atorvastatin 80mg daily
   SCH
   Captopril 12.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-31**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.8
   Tcurrent: 37.4
C (99.4
   HR: 63 (62 - 74) bpm
   BP: 129/62(78) {110/55(67) - 138/71(84)} mmHg
   RR: 16 (15 - 22) insp/min
   SpO2: 98%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
                  Total In:
                                                                  1,310 mL
                                                                     60 mL
   PO:
                                                                  1,110 mL
                                                                     60 mL
   TF:
   IVF:
                                                                    200 mL
   Blood products:
   Total out:
                                                                  2,025 mL
                                                                      0 mL
   Urine:
                                                                  1,275 mL
   NG:
                                                                    250 mL
   Stool:
                                                                    500 mL
   Drains:
   Balance:
                                                                   -715 mL
                                                                     60 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   243 K/uL
   9.9 g/dL
   82 mg/dL
   1.1 mg/dL
   27 mEq/L
   3.5 mEq/L
   22 mg/dL
   101 mEq/L
   135 mEq/L
   27.9 %
   12.2 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
                            [**2187-12-31**]  05:00 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   12.2
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   27.9
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   243
   Cr
   1.6
   1.4
   1.2
   1.1
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   82
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/4/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.6 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will uptitrate NPH
   to 17 U [**Hospital1 **] given elevated blood sugars.
   - Will need PCP [**Name9 (PRE) 2207**]
   RENAL FAILURE
 Improving.  Suspect acute renal failure in setting of
   poor perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 56-year-old male with a STEMI, s/p stenting of the posterolateral RCA. He has a history of hyperglycemia, bradycardia, and right-sided infarction. The patient's vital signs are:

* Temperature: 37.4C (99.4F)
* Heart rate: 63 bpm (62-74 bpm)
* Blood pressure: 129/62 mmHg (78/55 mmHg - 138/71 mmHg)
* Respiratory rate: 16 breaths per minute (15-22 breaths per minute)
* SpO2: 98%

The patient has a 1st-degree AV block, and his physical examination is limited due to lack of assessment in certain areas (peripheral vascular, skin, neurologic).

Laboratory results show:

* White blood cell count: 10.3-12.8 x 10^9/L
* Hemoglobin: 9.9-11.4 g/dL
* Platelet count: 214-243 x 10^9/L
* Creatinine: 1.1-1.6 mg/dL
* Troponin-T: 2.32-2.79 ng/mL
* Glucose: 82-286 mg/dL
* Other lab results are within normal limits.

The patient's conditions and potential complications are:

* Bradycardia: likely secondary to ischemia of the conduction system, and the patient is at risk for developing atrial fibrillation or ventricular tachycardia.
* Hyperglycemia: likely represents longstanding undiagnosed diabetes, and the patient is at risk for developing diabetic ketoacidosis or hyperosmolar hyperglycemic nonketotic syndrome.
* Renal failure: suspect acute renal failure in setting of poor perfusion and hyperglycemic hypovolemia, and the patient is at risk for developing chronic kidney disease.
* Right-sided infarction: the patient is at risk for developing right-sided heart failure and pulmonary edema.

The patient's medical management includes:

* Infusions of heparin sodium (prophylaxis) and NPH (insulin)
* ASA 325mg, clopidogrel 75mg, and atorvastatin 80mg daily
* Captopril 12.5mg TID
* Daily EKGs
* Monitoring of volume status and cardiac output
* Echo today
* Daily Cr and outpatient urine protein

The patient is participating in the ICE-T-TIMI-49 trial, a randomized controlled trial of low-dose IC tenecteplace during PCI for STEMIs. He will be contacted at 30-35 days by phone to assess for adverse events."
195662.0,278189,2187-12-31 06:52:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
 BLOOD CULTURED - At [**2187-12-30**] 10:00 AM
   Decreased BM overnight, had temp of 100.5 at MN.  Urine Cx resent and
   pending.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2187-12-30**] 10:00 PM
   Other medications:
   NPH 17/17 + SSI
   ASA 325mg
   Clopidogrel 75mg
   Atorvastatin 80mg daily
   SCH
   Captopril 12.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-31**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.8
   Tcurrent: 37.4
C (99.4
   HR: 63 (62 - 74) bpm
   BP: 129/62(78) {110/55(67) - 138/71(84)} mmHg
   RR: 16 (15 - 22) insp/min
   SpO2: 98%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
                  Total In:
                                                                  1,310 mL
                                                                     60 mL
   PO:
                                                                  1,110 mL
                                                                     60 mL
   TF:
   IVF:
                                                                    200 mL
   Blood products:
   Total out:
                                                                  2,025 mL
                                                                      0 mL
   Urine:
                                                                  1,275 mL
   NG:
                                                                    250 mL
   Stool:
                                                                    500 mL
   Drains:
   Balance:
                                                                   -715 mL
                                                                     60 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   243 K/uL
   9.9 g/dL
   82 mg/dL
   1.1 mg/dL
   27 mEq/L
   3.5 mEq/L
   22 mg/dL
   101 mEq/L
   135 mEq/L
   27.9 %
   12.2 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
                            [**2187-12-31**]  05:00 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   12.2
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   27.9
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   243
   Cr
   1.6
   1.4
   1.2
   1.1
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   82
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/4/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.6 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will uptitrate NPH
   to 17 U [**Hospital1 **] given elevated blood sugars.
   - Will need PCP [**Name9 (PRE) 2207**]
   RENAL FAILURE
 Improving.  Suspect acute renal failure in setting of
   poor perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
 BLOOD CULTURED - At [**2187-12-30**] 10:00 AM
   Decreased BM overnight, had temp of 100.5 at MN.  Urine Cx resent and
   pending.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2187-12-30**] 10:00 PM
   Other medications:
   NPH 17/17 + SSI
   ASA 325mg
   Clopidogrel 75mg
   Atorvastatin 80mg daily
   SCH
   Captopril 12.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-31**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.8
   Tcurrent: 37.4
C (99.4
   HR: 63 (62 - 74) bpm
   BP: 129/62(78) {110/55(67) - 138/71(84)} mmHg
   RR: 16 (15 - 22) insp/min
   SpO2: 98%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
                  Total In:
                                                                  1,310 mL
                                                                     60 mL
   PO:
                                                                  1,110 mL
                                                                     60 mL
   TF:
   IVF:
                                                                    200 mL
   Blood products:
   Total out:
                                                                  2,025 mL
                                                                      0 mL
   Urine:
                                                                  1,275 mL
   NG:
                                                                    250 mL
   Stool:
                                                                    500 mL
   Drains:
   Balance:
                                                                   -715 mL
                                                                     60 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   243 K/uL
   9.9 g/dL
   82 mg/dL
   1.1 mg/dL
   27 mEq/L
   3.5 mEq/L
   22 mg/dL
   101 mEq/L
   135 mEq/L
   27.9 %
   12.2 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
                            [**2187-12-31**]  05:00 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   12.2
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   27.9
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   243
   Cr
   1.6
   1.4
   1.2
   1.1
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   82
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/4/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.6 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.
   - Medical management with ASA, statin, plavix.  Now off integralin.
   - Daily EKGs
   - Will start captopril today.  No beta-blocker as bradycardic.
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - D/C pacer leads today as no longer with a rhythm that would indicate
   need for PPM and improving HR.
   - D/C lidocaine
   - No beta-blocker
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   - Gental hydration post-cath.
   - Monitor for signs of volume overload
   - Echo today
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  Off
   insulin gtt.  Based on gtt requirements of [**3-19**] U/hr (> 50 U/day) and 14
   unit sliding scale requirement in 12 hours off gtt.  Will uptitrate NPH
   to 17 U [**Hospital1 **] given elevated blood sugars.
   - Will need PCP [**Name9 (PRE) 2207**]
   RENAL FAILURE
 Improving.  Suspect acute renal failure in setting of
   poor perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with no prior medical history, who presented with a STEMI and was treated with stenting of the posteriorlateral RCA. He has been experiencing weakness, bradycardia, and hyperglycemia. The patient's cardiac enzymes have peaked, and his troponin and CK-MB levels are elevated, suggesting significant duration of ischemia and low chance of myocardial recovery.

The patient has been managed with aspirin, statin, and Plavix, and is being monitored for signs of volume overload and cardiac compromise. He has been started on captopril and will have daily EKGs. The patient's bradycardia is likely secondary to ischemia of the conduction system, and he has been placed on a pacer.

The patient has a history of hyperglycemia, which is likely representing longstanding undiagnosed diabetes. He has been off insulin for 12 hours and is being monitored for signs of hypoglycemia. The patient's renal function is improving, but he is still at risk for acute renal failure.

Potential Medical Complications:

1. Cardiac Complications: The patient is at risk for cardiac complications such as ventricular arrhythmias, cardiac arrest, and heart failure due to the extent of his myocardial infarction.
2. Renal Failure: The patient is at risk for acute renal failure due to poor perfusion, hyperglycemic hypovolemia, and diabetic nephropathy.
3. Infection: The patient is at risk for infection due to his compromised immune system and the presence of central lines.
4. Hypoglycemia: The patient is at risk for hypoglycemia due to the off-label use of insulin and the potential for medication errors.
5. Bleeding Complications: The patient is at risk for bleeding complications due to his thrombocytopenia and the use of anticoagulants.
6. Respiratory Complications: The patient is at risk for respiratory complications such as pneumonia and acute respiratory distress syndrome due to his compromised respiratory status and the presence of central lines.
7. Neurological Complications: The patient is at risk for neurological complications such as stroke and seizures due to his compromised cardiovascular status and the presence of central lines.

Recommendations:

1. Continue to monitor the patient's cardiac enzymes and troponin levels to assess for signs of cardiac compromise.
2. Monitor the patient's renal function and adjust his fluid and electrolyte management accordingly.
3. Monitor the patient's glucose levels and adjust his insulin dosing accordingly.
4. Monitor the patient's platelet count and adjust his anticoagulant dosing accordingly.
5. Monitor the patient's respiratory status and adjust his oxygen therapy and ventilation accordingly.
6. Monitor the patient's neurological status and adjust his anticoagulant dosing and oxygen therapy accordingly.
7. Consider placing the patient on a stress ulcer prophylaxis regimen to prevent gastrointestinal bleeding."
195662.0,278189,2187-12-31 06:52:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
 BLOOD CULTURED - At [**2187-12-30**] 10:00 AM
   Decreased BM overnight, had temp of 100.5 at MN.  Urine Cx resent and
   pending.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2187-12-30**] 10:00 PM
   Other medications:
   NPH 17/17 + SSI
   ASA 325mg
   Clopidogrel 75mg
   Atorvastatin 80mg daily
   SCH
   Captopril 12.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-31**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.8
   Tcurrent: 37.4
C (99.4
   HR: 63 (62 - 74) bpm
   BP: 129/62(78) {110/55(67) - 138/71(84)} mmHg
   RR: 16 (15 - 22) insp/min
   SpO2: 98%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
                  Total In:
                                                                  1,310 mL
                                                                     60 mL
   PO:
                                                                  1,110 mL
                                                                     60 mL
   TF:
   IVF:
                                                                    200 mL
   Blood products:
   Total out:
                                                                  2,025 mL
                                                                      0 mL
   Urine:
                                                                  1,275 mL
   NG:
                                                                    250 mL
   Stool:
                                                                    500 mL
   Drains:
   Balance:
                                                                   -715 mL
                                                                     60 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   243 K/uL
   9.9 g/dL
   82 mg/dL
   1.1 mg/dL
   27 mEq/L
   3.5 mEq/L
   22 mg/dL
   101 mEq/L
   135 mEq/L
   27.9 %
   12.2 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
                            [**2187-12-31**]  05:00 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   12.2
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   27.9
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   243
   Cr
   1.6
   1.4
   1.2
   1.1
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   82
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/4/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.6 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.  1^st degree
   AV block.
   - Medical management with ASA, statin, plavix.  .
   - Cont Lisinopril
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - Beta-blocker added tomorrow
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  NPH
   17 U [**Hospital1 **] given elevated blood sugars.
   -          Will need PCP [**Name9 (PRE) 2207**]
   [**Name Initial (PRE) **]          [**Name9 (PRE) 294**] C/s
   RENAL FAILURE
 Improving.  Suspect acute renal failure in setting of
   poor perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
 BLOOD CULTURED - At [**2187-12-30**] 10:00 AM
   Decreased BM overnight, had temp of 100.5 at MN.  Urine Cx resent and
   pending.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2187-12-30**] 10:00 PM
   Other medications:
   NPH 17/17 + SSI
   ASA 325mg
   Clopidogrel 75mg
   Atorvastatin 80mg daily
   SCH
   Captopril 12.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2187-12-31**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.8
   Tcurrent: 37.4
C (99.4
   HR: 63 (62 - 74) bpm
   BP: 129/62(78) {110/55(67) - 138/71(84)} mmHg
   RR: 16 (15 - 22) insp/min
   SpO2: 98%
   Heart rhythm: 1st AV (First degree AV Block)
   Height: 72 Inch
                  Total In:
                                                                  1,310 mL
                                                                     60 mL
   PO:
                                                                  1,110 mL
                                                                     60 mL
   TF:
   IVF:
                                                                    200 mL
   Blood products:
   Total out:
                                                                  2,025 mL
                                                                      0 mL
   Urine:
                                                                  1,275 mL
   NG:
                                                                    250 mL
   Stool:
                                                                    500 mL
   Drains:
   Balance:
                                                                   -715 mL
                                                                     60 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   GENERAL: WDWN male in NAD. Oriented x3. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line.
   Bradycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Mild crackles at bases.
   ABDOMEN: Soft, NTND. No HSM or tenderness.
   EXTREMITIES: No c/c/e. No femoral bruits. Pacer line in right femoral
   fossa.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   243 K/uL
   9.9 g/dL
   82 mg/dL
   1.1 mg/dL
   27 mEq/L
   3.5 mEq/L
   22 mg/dL
   101 mEq/L
   135 mEq/L
   27.9 %
   12.2 K/uL
        [image002.jpg]
                            [**2187-12-28**]  05:03 PM
                            [**2187-12-28**]  08:31 PM
                            [**2187-12-28**]  11:02 PM
                            [**2187-12-29**]  05:30 AM
                            [**2187-12-29**]  09:00 AM
                            [**2187-12-29**]  02:00 PM
                            [**2187-12-29**]  03:26 PM
                            [**2187-12-29**]  06:00 PM
                            [**2187-12-30**]  04:24 AM
                            [**2187-12-31**]  05:00 AM
   WBC
   10.3
   11.8
   10.8
   11.4
   12.8
   12.2
   Hct
   38.3
   35.1
   35.3
   30.3
   30.8
   27.9
   Plt
   [**Telephone/Fax (3) 2213**]00
   214
   243
   Cr
   1.6
   1.4
   1.2
   1.1
   TropT
   2.79
   2.32
   Glucose
   [**Telephone/Fax (3) 2214**]79
   286
   185
   82
   Other labs: PT / PTT / INR:14.8/46.9/1.3, CK / CKMB /
   Troponin-T:273/4/2.32, ALT / AST:70/63, Alk Phos / T Bili:113/1.1,
   Lactic Acid:2.1 mmol/L, Albumin:3.4 g/dL, LDH:692 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.3 mg/dL, PO4:2.6 mg/dL
   Assessment and Plan
   56 M with no PMH, Jehova's witness p/w weakness, bradycardia,
   hyperglycemia, STEMI now s/p stenting of posterorlateral RCA.
   Infarction likely of AV node causing bradycardia
   ST-ELEVATION MYOCARDIAL INFARCTION - Patient with significant
   right-sided infarction.  Elevated troponin/CK-MB and history suggest
   significant duration of ischemia and low chance of myocardial
   recovery.  CKs have peaked.  Patient is s/p RCA stenting.  1^st degree
   AV block.
   - Medical management with ASA, statin, plavix.  .
   - Cont Lisinopril
   BRADYCARDIA - Likely seconday to ichemia of conduction system.  Patient
   appears to have isorhythmic dissociation.  Pacer wires placed in cath
   lab.  Rhythm progressed from CHB to 2nd-degree to 1st -degree
   (conduction delay).
   - Beta-blocker added tomorrow
   PUMP - Will need careful monitoring of volume status as severly
   dehydrated from hyperglycemia and likely poor cardiac output secondary
   to right-sided MI.
   HYPERGLYCEMIA - Hyperglycemia likely represents longstanding
   undiagnosed diabetes.  HbA1c 11.9 indicative of chronic disease.  NPH
   17 U [**Hospital1 **] given elevated blood sugars.
   -          Will need PCP [**Name9 (PRE) 2207**]
   [**Name Initial (PRE) **]          [**Name9 (PRE) 294**] C/s
   RENAL FAILURE
 Improving.  Suspect acute renal failure in setting of
   poor perfusion and hyperglycemic hypovolemia.  [**Month (only) 11**] represent diabetic
   nephropathy if more chronic.  Improved today.
   - Daily Cr.
   - Outpatient urine protein.
   CLINICAL TRIAL - Patient is on ICE-T-TIMI-49 trial, a RCT of low dose
   IC tenecteplace during PCI for STEMIs.  He received tenecteplase or
   placebo.  Patient had ECK at noon and 2 PM, and CBC at 5PM and 11AM, as
   well as CK, CK-MB and Tropin T q8 hours for 3 sets.  He will be
   contact[**Name (NI) **] at 30-35 days by phone to assess for adverse advents
   FEN: Diabetic, cardiac diet.
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with SQ heparin
   -Bowel regimen colase/senna if needed
   CODE: Confirmed full
   DISPO: CCU
   CONTACT: Wife Cell [**Telephone/Fax (1) 2146**];  [**Name2 (NI) 1246**] [**Telephone/Fax (1) 2147**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2187-12-28**] 12:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications can be identified:

Summary:

The patient is a 56-year-old male with no prior medical history, who presented with a ST-Elevation Myocardial Infarction (STEMI) and was treated with stenting of the posteriorlateral RCA. He has a history of weakness, bradycardia, and hyperglycemia. The patient's laboratory results show elevated troponin and CK-MB levels, indicating significant myocardial damage. He has also developed a 1st-degree AV block and is being treated with ASA, statin, and Plavix. The patient's condition is complicated by dehydration, hyperglycemia, and likely poor cardiac output secondary to right-sided MI.

Potential Medical Complications:

1. Cardiac Complications:
	* Increased risk of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, due to the 1st-degree AV block.
	* Potential for further myocardial damage or infarction due to ongoing ischemia.
	* Increased risk of cardiac failure, particularly if the patient's cardiac output remains compromised.
2. Renal Complications:
	* Acute kidney injury or acute renal failure due to hypovolemia, hyperglycemia, and poor perfusion.
	* Chronic kidney disease or diabetic nephropathy if the patient's hyperglycemia is not well-controlled.
3. Infection Complications:
	* Increased risk of sepsis or septic shock due to the patient's immunocompromised state.
	* Potential for nosocomial infections, such as ventilator-associated pneumonia (VAP) or catheter-related bloodstream infections.
4. Gastrointestinal Complications:
	* Risk of gastrointestinal bleeding due to the patient's anticoagulation therapy and potential for poor platelet function.
	* Potential for gastrointestinal ischemia or infarction due to reduced blood flow.
5. Neurological Complications:
	* Risk of cerebral edema or stroke due to the patient's cardiac condition and potential for hypoperfusion.
	* Potential for seizures or altered mental status due to electrolyte imbalances or medication side effects.

It is essential to closely monitor the patient's condition and adjust his treatment plan accordingly to minimize the risk of these complications and improve his overall outcome."
